Genting Singapore starting to lose grip on mass segment share

Here's why it could do more harm.

According to CIMB, Genting Singapore’s (GENS) 4Q13 earnings disappointed for a third quarter in a row but the underlying trend in VIP growth and higher market share at Resorts World Sentosa (RWS) is positive.

"We still hold the view that GENS’s earnings will bottom out and recover in 2014," CIMB said.

Here's more from CIMB:

One of the key reasons why GENS’s 4Q13 was below expectations was the rate provisioning on VIP receivables.

It nearly doubled to S$56m from a regular run rate of S$30m. Management believes it is being conservative as it wrote off all receivables that were more than 365 days old.

However, this could be a harbinger of further increases in the provisioning rate, revealing a structural bad debt problem in the business.

Although GENS is gaining more of the VIP business, Marina Bay Sands continues to benefit with better mass market numbers due to its location and convention facilities.

Losing market share in the mass segment is not good in the long run because it is a higher-margin business.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare